Asarina Pharma AB (publ) reported earnings results for the half year ended June 30, 2023. For the half year, the company reported net loss was SEK 9.49 million compared to SEK 8.2 million a year ago. Basic loss per share from continuing operations was SEK 0.42 compared to SEK 0.44 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.83 SEK | -1.43% | -7.57% | -5.68% |
02-27 | Asarina Pharma AB Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | Asarina Pharma AB Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-5.68% | 1.78M | |
+7.64% | 113B | |
+10.98% | 106B | |
+0.41% | 22.27B | |
-11.89% | 22.22B | |
-5.99% | 19.43B | |
-37.36% | 17.87B | |
-6.04% | 17.24B | |
+6.76% | 14.29B | |
+36.17% | 12.52B |
- Stock Market
- Equities
- ASAP Stock
- News Asarina Pharma AB
- Asarina Pharma AB Reports Earnings Results for the Half Year Ended June 30, 2023